Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg. (Q40817492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Chia-Chi Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Kuo-Chih Tseng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Tsai-Yuan Hsieh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Tai-Chung Tseng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Hans Hsienhong Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

English

0 references

publication date

5 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

31 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

1286-1294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

Global control of hepatitis B virus infection.

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Fighting against viral hepatitis: lessons from Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Perspectives and control of hepatitis B virus infection in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Impact of therapy on the outcome of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.109

Discontinuation of long-term NA therapy in HBeAg-negative chronic hepatitis B

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27045923

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27045923

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/AJG.2016.109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json

release_cyvmofqlwvabpphetdibgc2kf4

31 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cyvmofqlwvabpphetdibgc2kf4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27045923%20AND%20SRC:MED&resulttype=core&format=json